Through the mechanistic understanding of disease, we intend to usher in a new era of discovery, development and biomedical innovation originating from or actively involving Sub-Saharan Africa.
Through the mechanistic understanding of disease, we intend to usher in a new era of discovery, development and biomedical innovation originating from or actively involving Sub-Saharan Africa.
Ultimately, we seek to shorten the distance between the laboratory and the bedside through the expeditious development of value-based novel and improved methods of diagnosis, treatment options, and disease prevention for all.
With a base in Ghana, West Africa, we understand that solving today’s problems is just as important as tackling future challenges.
For this and other patient-centric reasons, we are committed to a Test-Intercept/Treat approach using our synergized ecosystem that is optimized for today’s patients and positioned to shape the future of healthcare in the region.